Cite
APA Citation
Avouac, J., Molto, A., Abitbol, V., Salcion, A., Gutermann, L., Conort, O., Chast, F., Jeunne, C. L., Goulvestre, C., Chaussade, S., Kahan, A., Roux, C., Allanore, Y., & Dougados, M. (n.d.). sAT0163 Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory rheumatic diseases in daily clinical practice: the experience of cochin hospital, paris, france. Annals of the rheumatic diseases, 76, 831–832. http://access.bl.uk/ark:/81055/vdc_100135139165.0x000062